British Journal of Cancer </bjc/> 	
	My Account <http://www.nature.com/myaccount> 	E-Alerts
<http://www.nature.com/nams/svc/myaccount/save/ealert?list_id=22>
Subscribe </bjc/prices.html> 	Register </register/bjc>

SEARCH 		  		  	Search British Journal of Cancer
<http://search.nature.com/search/?sp_a=sp1001702d&sp_t=advanced&sp_x_1=ujournal&sp_q_1=British
Journal of Cancer> 	 advanced search
<http://search.nature.com/search/?sp_a=sp1001702d&sp_t=advanced&sp_x_1=ujournal&sp_q_1=British
Journal of Cancer> 	Help <http://nature.custhelp.com/> 	 help
<http://nature.custhelp.com/> 	Site Index
<javascript:popup('/bjc/siteindex.html','SiteIndex','615','490','no')>
 site index
<javascript:popup('/bjc/siteindex.html','SiteIndex','615','490','no')>
14 January 2008 

		
	Journal
 		Home </bjc/>
 		Current issue </bjc/journal/v98/n1/>
 		Previous issue </bjc/journal/v97/n12/>
 		Advance Online Publication </bjc/journal/vaop/ncurrent/>
 		Archive </bjc/journal/>
 		Author index </bjc/author_index/>
 		Keyword index </bjc/keyword_index/>
 		Aims & scope </bjc/about/aims_scope.html>
 		Editors & editorial board </bjc/editor.html>
 		Contacts </bjc/contacts.html>
 		Web focus <journal/v96/n1r/index.html>
	For authors
 		Submitting to BJC </bjc/submit.html>
 		Before you submit </bjc/submit.html#before>
 		How to submit </bjc/submit.html#how>
 		What you can expect </bjc/submit.html#expect>
 		Author Licence </bjc/bjc_licence_to_publish.pdf>
	Services
 		Receive Table of Contents by email
<http://www.nature.com/nams/svc/myaccount/save/ealert?list_id=22>
 		Online sample copy FREE </bjc/sample_issue.html>
 		Order sample copy </aj/sample_copy.html>
 		Purchasing articles </bjc/purchase.html>
 		Reprints & permissions </reprints/>
 		Prices </bjc/prices.html>
 		Indexed in </bjc/indexed_in.html>
 		Reprints & permissions </bjc/reprints.html>
 		For advertisers </bjc/advertisers.html>
 		Press releases </bjc/press_releases/>
 		About nature publishing group <http://npg.nature.com/>
Cancer Research UK <javascript:popup('/bjc/cruk.html','cruk','467','560')>



		
Submitting an article


    	Submitting to BJC
      		What we publish <#publish>
      	Before you submit <#before>
      		Ethics <#ethics>
      		Authorship <#authorship>
      		BJC's Licence to Publish <#LTP>
      		Permissions <#permissions>
      		Availability of materials <#materials>
      	How to submit <#how>
      		Manuscripts should be submitted to <#mans>
      		Manuscript format <#man2>
      		Figures <#figures>
      		Tables <#tables>
      		Supplementary online material <#supp>
      	What you can expect <#expect>
      		Efficient, fast review and publication <#expect>
      		Exposure - widest possible readership <#exposure>
      		Extending science further - global collaborations <#extending>
      	  	 


    What we publish

    BJC welcomes the submission of high quality original and innovative
    research findings that are relevant to understanding the etiology of
    cancer and to improving the treatment and survival of patients.

        * Full-length papers (5-6 printed pages) and short
          communications (2-4 pages) are published across the entire
          spectrum of cancer research. There are additional facilities
          for publishing supplementary material and colour figures online
        * Single case reports are very rarely accepted and only if they
          illustrate a point of general interest
        * Minireviews on current topics, some longer reviews and book
          reviews are usually invited by the editor, but potential
          authors are encouraged to approach the journal with
          suggestions for these and other relevant articles
        * Editorials and letters to the editor on matters arising from
          published material are published at the editor's discretion
        * BJC has no submission charges.




Before you submit
back to top <#top>


    Ethics

    The BJC does not accept work that is funded in any part by tobacco
    industry sources.

    Typescripts that contain the results of human and/or animal studies
    will be accepted for publication only if it is made clear that a
    high standard of ethics was applied in carrying out the investigations.

    Papers reporting clinical studies should, where appropriate, contain
    a statement that they have been carried out with ethical committee
    approval. Papers disregarding the welfare of experimental animals
    will be rejected. Authors may find the UKCCCR 'Guidelines for the
    Welfare of Animals in Experimental Neoplasia
    </bjc/UKCCCR_Guidelines.pdf>' helpful in this regard. These were
    published in British Journal of Cancer (1998) 77(1): 1 - 10. Printed
    copies may be obtained from: UKCCCR, PO Box 123, Lincoln's Inn
    Fields, London WC2A 3PX, UK.



    Authorship

    A paper is accepted for review by BJC on the understanding that:

        * it has not been and will not be submitted simultaneously to
          another journal, in whole or in part
        * it reports previously unpublished work
        * all named authors have agreed to submit the paper to BJC in
          its present form
        * if the paper is accepted, all the authors will observe the
          terms of the Licence to Publish, and will seek the consent of
          the publishers acting for the owners of the journal, in any
          other circumstance.

    A signed statement that all named authors have agreed to the
    submission and have participated in the study to a sufficient extent
    to be named as authors should accompany submitted manuscripts. If
    the authorship of a paper is changed in any way after it has been
    reviewed, the Editor will require a letter, signed by all authors
    named on the original or on the revised submission, explicitly
    agreeing to the change.

    The Editors reserve the right to make literary corrections



    BJC's Licence to Publish (LTP)

    From the beginning of Volume 97 (July 2007) BJC adopted a new
    Licence to Publish (LTP) </bjc/bjc_licence_to_publish.pdf> This
    agreement has many benefits for authors. It allows authors to retain
    their copyright, whilst transferring to Cancer Research UK, the
    owners of BJC, all the rights that it and NPG, the publisher of the
    journal, need in order to protect, publish, distribute and market
    papers to maximum effect.

    Under the terms of this LTP </bjc/bjc_licence_to_publish.pdf>,
    authors will retain the rights to reuse material taken from their
    papers in their own future publications and for teaching purposes
    within their own institutions. If the acknowledgements specified in
    the LTP </bjc/bjc_licence_to_publish.pdf> are made and a link is
    provided to the published paper, the new licence allows authors to
    post a copy of the final accepted manuscript to their own website,
    to their employer's website or to that of the funder of the work
    described. The final accepted manuscript may be made available in
    this way, six months after the date of publication of the print
    issue in which the paper appears. The LTP
    </bjc/bjc_licence_to_publish.pdf> also allows the deposit of final
    accepted manuscripts in repositories such as PubMed Central, six
    months after the date of publication of the print issue in which the
    finished paper appears.

    The LTP </bjc/bjc_licence_to_publish.pdf> will be granted on an
    exclusive basis unless authors choose the option of paying a fee to
    publish their paper under the terms of BJC Open. Please note that
    BJC will not discuss BJC Open with authors until their paper has
    been formally accepted for publication, at which time they may
    contact the Editorial Office.

    For further details authors should consult the current version of
    our Licence to Publish (LTP) </bjc/bjc_licence_to_publish.pdf> which
    is available on this website. If requested, it will be sent to the
    corresponding author, who is asked to follow precisely the
    instructions given.

    Authors who signed our previous copyright transfer should continue
    to observe its conditions.

    It is our intention to open the archives of BJC for all papers that
    have been published for more than a year. This will begin some time
    during 2008 and will be announced on this website. The new licence
    (LTP </bjc/bjc_licence_to_publish.pdf>) also sets out the terms
    under which papers will then be made available.



    Permissions

    Written permission to reproduce borrowed material (illustrations,
    tables and photographs) must be obtained. Authors must ensure that
    appropriate permission has been obtained for the publication of
    identifiable clinical photographs.

    Borrowed and previously published material should be acknowledged in
    the captions in this style: 'Reproduced by kind permission of . . .
    (publishers) . . . from . . . (reference).' It is the responsibility
    of the author to obtain all such permissions from the original
    publishers and authors, and to submit them with the manuscript.



    Availability of materials

    It is understood that, by publishing a paper in BJC, authors agree
    that, wherever possible, they will make available to colleagues in
    academic research any of the cells, nucleic acids, antibodies, etc.
    used in the research reported and not available from commercial
    suppliers.



How to submit
back to top <#top>



    Manuscripts should be submitted to:

    BJC Main Editorial Office
    UCL Cancer Institute
    Rockefeller Building (B049)
    Gower Street
    London
    WC1E 6BT
    UK

    A printed original and one good copy are required of both text and
    illustrations. Duplicates of photographs must be of the same
    standard as the originals.

    It would be helpful if you could enclose a CD-ROM containing all
    files and the text of the covering letter. Please ensure that the
    disk and typescript match exactly. Indicate on the label attached to
    your disk, your name, typescript title and name of the word
    processing package used. Please ensure that all sections of the text
    your article are in a single file in the order set out below and
    that the references are in the correct style. Tables, with their
    captions, and figure legends should be supplied on disk in a
    separate file. Line illustrations should also be on the disk, but
    must be in a separate file and not embedded in the text. It is
    helpful if electronic versions of photographs are also included on
    the disk, in addition to the prints submitted with the manuscript.

    The /BJC/ will make every effort to return photographic material
    after refereeing, but will not normally return manuscripts.



    Manuscript format

    Manuscripts, which must be written in English, should be typed using
    double spacing and printed out on one side only of good quality
    paper. To assist the reviewing of your manuscript, you should
    provide a wide margin (at least 3cm) all round the text. Manuscripts
    must be concise and should not normally exceed approximately 5
    printed pages. This is equivalent to approximately 5000 - 5500
    words. This total should be reduced when non-text material is
    included. As a rough guide, assume one figure, one table and 10
    references are each equivalent to 200 words.

    Overly long manuscripts may be rejected on that basis.

        * *Full papers *should be divided into sections: Abstract;
          Introduction; Materials and methods; Results; Discussion;
          Acknowledgements; and References.
        * *Short communications* of approximately 1500 words, should
          have the section headings above and a briefer abstract.
        * *Minireviews* should have 3000-3500 words, with appropriate
          reductions for one or two figures or tables, and should
          include a brief abstract, an introduction, a conclusion, and
          no more than 30 references.


    /Title page
    /Your title page, numbered as 1, should give the title in bold
    letters (not normally exceeding 100 letters), a running title (not
    to exceed 50 letters) and the authors' names (as they are to
    appear), affiliations and complete addresses, including postal (zip)
    codes. Indicate the corresponding author clearly. Both an e-mail
    address and a full postal address are required for the corresponding
    author.


    /Abstracts and keywords /
    A summary of the content of your manuscript, a maximum of 200 words
    (or 50 words for a short communication or minireview), should be
    provided on a separate sheet following the title page. A list of
    three to six keywords should follow the summary.


    /Units & abbreviations
    /Avoid abbreviations in the title and abstract. All unusual
    abbreviations should be fully explained at their first occurrence in
    the text. All measurements should be expressed in SI units. For more
    detailed recommendations, authors may consult Baron DN. (1988).
    /Units, Symbols, and Abbreviations: a guide for biological and
    medical editors. / 4th ed. London: Royal Soc Med.


    /Drug names
    /Generic drug names should be used.


    /Reference format
    /Only papers closely related to the author's work should be quoted,
    and these should wherever possible be original papers rather than
    reviews. Exhaustive lists should be avoided. Citation of conference
    proceedings or meeting abstracts should also be avoided unless there
    is no other reference. References in the text should be made by
    giving, in brackets, the author's surname, with the year of
    publication. When the reference is to a specific part of a book, the
    page number should also be cited. When reference is made to a work
    by three or more authors, the first name followed by /et al/, should
    be used for all citations in the text (Weiss /et al/, 2001). If
    several papers by the same first author and from the same year are
    cited, a, b, c, etc, should be added after the year of publication.
    Authors are asked to check the accuracy of all references before
    submitting a manuscript. References should be brought together at
    the end of the paper in alphabetical order, where titles of papers
    and all authors names should be given in full. Names of journals
    should be abbreviated as in Index Medicus, followed by the volume
    number and the initial and final page numbers, e.g.:

    Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A (1997)
    Comprehensive allelotyping of hepatocellular carcinoma. /Oncogene
    /*14*: 2927 ? 2933

    Wherever possible, include the digital object identifier (DOI), from
    the article's title page. Please note the following example:

    Nanduri and Zimniak P (1999) /Arch Biochem Biophys/ *362*: 167 -
    174, doi:10.1054/abbi.1998.1009

    References to books and monographs should appear as in the following
    examples:

    Means JH (1984) The Thyroid and its Diseases. Lippincott: Philadelphia

    Stevenson AC (1966) Sex chromatin and sex ratio in man. In Sex
    Chromatin, Moore A. (ed) pp 405 - 425. W. B. Saunders: Philadelphia



    Figures

    All line drawings and photographic prints should be submitted on
    separate sheets and be of a reproducible quality (not photocopies).
    They must be clearly marked (by a label pasted on the back or in
    soft pencil) with the figure number (Arabic numeral). The top of the
    figure should be indicated with an arrow. Please make sure each
    figure is cited in order within the text, e.g. (Figure 2). Captions
    must be typed, double spaced on a separate sheet.

    /
    Photographs and photomicrographs/
    should be submitted unmounted. Glossy prints should not be
    retouched, and should be chosen to exclude technical artefacts.
    Magnification should be indicated by a line, representing a defined
    length, included within the photograph. Areas of key interest and/or
    critical reproduction should be indicated on a photocopy. All
    annotation and lettering should also be indicated on a photocopy and
    should not be added to the original print. Clearly contrasted and
    focused prints are essential for adequate reproduction. Two
    originals of all photographs must be submitted, or four where
    photocopies are likely to prove unsuitable for refereeing purposes.

    /
    Colour in print/
    Full colour illustrations may be included in the printed text, at
    the discretion of the editor. However, a charge may be made to the
    author to cover the extra costs incurred in originating and printing
    colour illustrations. It is helpful if authors who submit colour
    figures indicate in their covering letter whether they are willing,
    in principle, to meet these costs. Prior to publication, authors
    will be advised of the costs, which depend on the size and quantity
    of colour illustrations.

    /
    Colour online/
    We are usually able to substitute colour versions of illustrations
    in the online journal at no additional cost. Authors wishing to take
    advantage of this facility are asked to submit both a high contrast
    black and white print for the printed journal and a colour print and
    file for the electronically published version
    <javascript:popup('/bjc/colour.html','colour','600','600')>.



    Tables

    Tables should be as few as possible and should present only
    essential data. Each must be typed on a separate sheet with a title
    or caption and clearly numbered. Please make sure each table is
    cited within the text, e.g. (Table 3).



    Supplementary online material

    Authors wishing to include additional material supporting a paper
    for which there is no space in the printed journal, may wish to have
    this made available online with the paper on the BJC website. These
    supplementary materials must be submitted with the original
    manuscript and will be shown to referees.

    This allows papers to have greater depth, online enhancements, such
    as video clips and additional data sets, making them more useful to
    fellow specialists in the field who require detail, without
    distracting more general readers.

    Authors should ensure that supplementary information is supplied in
    its FINAL format because it is not subedited and will appear online
    exactly as submitted. It cannot be altered, nor can new
    supplementary information be added, after the paper has been
    accepted for publication.



What you can expect 	back to top <#top>



    Efficient, fast review and publication

    Authors who choose to publish in BJC can be assured that its own
    editorial team and the staff at NPG are committed to maintaining the
    highest possible quality and standards at all stages of review and
    then in processing accepted papers for publication.

    BJC is using a web-based manuscript handling system for handling
    submitted papers during the review stages and is committed to
    reducing the time it takes to reach a decision about a manuscript as
    far as is consistent with good decision making. All submissions
    (provided there are no overriding problems of format) are assessed
    by BJC?s specialist editors. Those papers that are judged unlikely
    to meet BJC?s acceptance criteria are returned promptly, so that
    their authors may submit them elsewhere.

    /
    Proofs/
    Page proofs are usually sent electronically as email attachments to
    the corresponding author for checking. The proofs plus any minor
    corrections must be returned to the Production Editor by fax or post
    within 48 hours of receipt. Failure to do this will result in delays
    in publication.

    /
    Offprints
    /Offprints may be ordered on a form that will accompany your page
    proofs.

    /
    Fast track publication
    /BJC has a fast-track system for publication of recent, important
    findings. After review, and at the discretion of the editor, this
    material will appear in the next available issue.

    /
    Online publication
    /Papers published in BJC are released online several days ahead of
    the mailing of the printed issue. The online version of the paper is
    identical to the printed version and is not a preliminary, unedited
    version, thus maintaining BJC?s tradition of excellence and also the
    integrity of the published record.

    /
    Digital Object Identifier
    /Nature Publishing Group assigns a unique digital object identifier
    (DOI) to every article it publishes. The DOI initiative is an
    international effort for electronic content identification and is
    guided by the International DOI Foundation, composed primarily of
    academic publishers and societies. The DOI appears on the title page
    of the article. It is assigned after the article has been accepted
    for publication and persists throughout the lifetime of the article.
    It is important to include the article's DOI in the reference as
    volume and page information is not always available for articles
    published online. The DOI should be cited in a reference as follows:

    Clayton, JD, Kyriacou, CP, Reppart SM (2000) Keeping time with the
    human genome. Nature *409*: 829 - 831, doi:10.1038/35057062



    Exposure ? widest possible readership

    NPG journals, including BJC, are available online via site licences
    <http://npg.nature.com/npg/servlet/Content?data=xml/08_intro.xml&style=xml/08_intro.xsl>
    to academic, corporate and government institutions and consortia.
    BJC is available to members of these institutions at the click of a
    mouse, adding speed and visibility to authors' research papers.

    /
    Regular free e-mail alerts
    /NPG now reaches half a million scientists and researchers globally,
    via e-alerts sent when new issues go live on journal websites.
    E-alerts are sent to all who have signed up to receive them for BJC,
    currently many tens of thousands, thus ensuring additional exposure
    for BJC authors.
    Recipients click through to the full article if they subscribe or
    work at an institution with a site licence, or can click through to
    the article's abstract.

    /
    Cancer portal
    /Nature Cancer Update is a one-stop resource for cancer news,
    providing highlights of the latest research and policy developments
    from the Nature Publishing Group titles, including BJC, and cancer
    news from elsewhere.

    /
    Abstracting and indexing
    /BJC is included in the leading abstracting and indexing services
    including ISI, MEDLINE, EMBASE and BIOSIS. Extensive reference
    linking to MEDLINE, ISI, Chemport and others via services such as
    Crossref and DOI numbers provide seamless online linking between
    articles and databases.

    /
    Media coverage
    / BJC features several of the papers and reviews from each of its
    issues on its own website, thus increasing their exposure. Cancer
    Research UK occasionally issues press releases about BJC articles.
    Authors who wish to feature their work in local media are invited to
    contact the Main Editorial Office.



    Extending science further ? global collaborations

    BJC has enthusiastically joined NPG in supporting projects aimed at
    making current research available to a broader community of
    scientists and practitioners.



    The HINARI project

    BJC (and all NPG journals) are in WHO's HINARI (Health InterNetwork
    Access to Research Initiative) scheme which provides free access to
    public institutions in developing countries.



back to top <#top>

		
Print ISSN: 0007-0920 | Online ISSN: 1532-1827 	© 2007 Cancer Research UK
Privacy Policy
<http://npg.nature.com/npg/servlet/Content?data=xml/08_privacy.xml&style=xml/08_privacy.xsl>


